SCHEMBL913447

SCHEMBL913447

c1ccc(Cc2cccc(-c3ccccn3)n2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.59
KDM4E B2RXH2 4/20 0.59
LMNA P02545 3/20 0.59
CCR1 P32246 3/20 0.59
CCR5 P51681 3/20 0.59
CCR8 P51685 3/20 0.59
L3MBTL1 Q9Y468 3/20 0.59
HTT P42858 3/20 0.59
TP53 P04637 2/20 0.59
ALOX15 P16050 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
ALPL P05186 1/20 0.59
HSP90AA1 P07900 1/20 0.59
ALPI P09923 1/20 0.59
ALPG P10696 1/20 0.59
MAPK1 P28482 1/20 0.59
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP1A2 P05177 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30637256 1.00 SMN1; SMN2 (0.59) SMN1; SMN2KDM4ELMNACCR1CCR5
SCHEMBL24254614 0.90 KDM4E (0.55) SMN1; SMN2KDM4ELMNACCR1CCR5
SCHEMBL18769070 0.79 KDM4E (0.65) SMN1; SMN2KDM4ELMNACCR1CCR5
SCHEMBL13830900 0.79 RAB9A (0.58) SMN1; SMN2L3MBTL1TDP1NPC1RAB9A
SCHEMBL6084743 0.79 NPC1 (0.55) SMN1; SMN2KDM4ELMNACCR1CCR5
SCHEMBL11391346 0.79 L3MBTL1 (0.54) SMN1; SMN2KDM4ELMNACCR1CCR5
SCHEMBL29373231 0.78 L3MBTL1 (0.68) SMN1; SMN2LMNAL3MBTL1ALOX15TDP1
SCHEMBL64435 0.78 L3MBTL1 (0.68) SMN1; SMN2LMNAL3MBTL1ALOX15TDP1
SCHEMBL11330543 0.78 KCNH2 (0.62) SMN1; SMN2L3MBTL1TDP1RAB9AALDH1A1
SCHEMBL313802 0.78 KDM4E (0.63) SMN1; SMN2KDM4ELMNACCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114380850-B Gold-containing metal complexes, mixtures, compositions and organic electronic devices 广州华睿光电材料有限公司 2023-11-28 CN disclosed
CN-111278836-B Metal organic complex and application thereof in organic electronic device 广州华睿光电材料有限公司 2023-08-29 CN disclosed
US-8415473-B2 Luminescent gold(III) compounds for organic light-emitting devices and their preparation VERSITECH LIMITED (CN) 2013-04-09 US disclosed
US-8372977-B2 Luminescent gold(III) compounds containing bidentate ligand for organic light-emitting devices and their preparation THE UNIVERSITY OF HONG KONG (CN) 2013-02-12 US disclosed
US-20110012093-A1 LUMINESCENT GOLD(III) COMPOUNDS CONTAINING BIDENTATE LIGAND FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION THE UNIVERSITY OF HONG KONG (CN) 2011-01-20 US disclosed
WO-2011006353-A1 LUMINESCENT GOLD(III) COMPOUNDS CONTAINING BIDENTATE LIGAND FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION THE UNIVERSITY OF HONG KONG (CN) 2011-01-20 WO disclosed
US-20090278453-A1 LUMINESCENT GOLD(III) COMPOUNDS FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2009-11-12 US disclosed
US-7572912-B2 Containing a tridentate ligand and having at least one strong sigma -donating group; compounds can be used as electrophosphorescent material in OLEDs to give strong electroluminescence with high efficiency. UNIVERSITY OF HONG KONG (CN) 2009-08-11 US disclosed
US-20060091378-A1 Luminescent gold (III) compounds, their preparation, and light-emitting devices containing same VERSITECH LIMITED (CN) 2006-05-04 US disclosed
WO-2006045235-A1 LUMINESCENT GOLD(III) COMPOUNDS, THEIR PREPARATION, AND LIGHT-EMITTING DEVICES CONTAINING SAME THE UNIVERSITY OF HONG KONG (CN) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060091378-A1 Luminescent gold (III) compounds, their preparation, and light-emitting devices containing same LBR, IK, POLL SMN1; SMN2 4843/4885KDM4E 866/4885LMNA 304/4885
US-20110012093-A1 LUMINESCENT GOLD(III) COMPOUNDS CONTAINING BIDENTATE LIGAND FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION CHRM1, CHRM5, CHRM2 SMN1; SMN2 3590/4885KDM4E 449/4885LMNA 2626/4885
US-20090278453-A1 LUMINESCENT GOLD(III) COMPOUNDS FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION LBR, IK, POLL SMN1; SMN2 4753/4885KDM4E 1903/4885LMNA 496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.